These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30552954)

  • 21. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
    Hayashi K; Hayashi T; Miyazawa K; Tomoda A
    J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
    Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A
    J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penciclovir cream--improved topical treatment for herpes simplex infections.
    Schmid-Wendtner MH; Korting HC
    Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral activity of famciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
    Ashton RJ; Abbott KH; Smith GM; Sutton D
    J Antimicrob Chemother; 1994 Aug; 34(2):287-90. PubMed ID: 7814291
    [No Abstract]   [Full Text] [Related]  

  • 25. Prodrugs of herpes simplex thymidine kinase inhibitors.
    Yanachkova M; Xu WC; Dvoskin S; Dix EJ; Yanachkov IB; Focher F; Savi L; Sanchez MD; Foster TP; Wright GE
    Antivir Chem Chemother; 2015 Apr; 24(2):47-55. PubMed ID: 26463822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent cutaneous neonatal herpes caused by Herpes simplex virus-2.
    Imafuku S; Ohta E; Yoshimura K; Yasumoto S; Hirose S; Nakayama J
    J Dermatol; 2012 Jul; 39(7):671-2. PubMed ID: 21955135
    [No Abstract]   [Full Text] [Related]  

  • 28. Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus.
    Hostetler KY; Parker S; Sridhar CN; Martin MJ; Li JL; Stuhmiller LM; van Wijk GM; van den Bosch H; Gardner MF; Aldern KA
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11835-9. PubMed ID: 8265634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.
    Collins P; Oliver NM
    Am J Med; 1982 Jul; 73(1A):96-9. PubMed ID: 7102714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged detection of herpes simplex virus type 2 (HSV-2) DNA in cerebrospinal fluid despite antiviral therapy in a patient with HSV-2-associated radiculitis.
    Ganzenmueller T; Karaguelle D; Schmitt C; Puppe W; Stachan-Kunstyr R; Bronzlik P; Sauerbrei A; Wegner F; Heim A
    Antivir Ther; 2012; 17(1):125-8. PubMed ID: 22267477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon).
    Yamamura J; Koyasu M; Sato H; Kurokawa M; Yoshida Y; Amahabu Y; Shiraki K
    J Dermatol Sci; 1996 Apr; 12(1):50-5. PubMed ID: 8740461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
    Himaki T; Masui Y; Chono K; Daikoku T; Takemoto M; Haixia B; Okuda T; Suzuki H; Shiraki K
    Antiviral Res; 2012 Feb; 93(2):301-304. PubMed ID: 22155691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
    Lebel A; Boivin G
    J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic Inactivation of Herpes Simplex Viruses.
    Monjo AL; Pringle ES; Thornbury M; Duguay BA; Monro SMA; Hetu M; Knight D; Cameron CG; McFarland SA; McCormick C
    Viruses; 2018 Sep; 10(10):. PubMed ID: 30274257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
    Machida H; Ikeda T; Ashida N
    Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
    Field HJ; De Clercq E
    J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.